You are here: Welcome to the MPKB » Welcome to the MPKB » Marshall Protocol » Concerns about progress on the Marshall Protocol
Home

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision		Previous revision
home:mp:progress [04.29.2019] – [Concerns about progress on the Marshall Protocol] sallieqhome:mp:progress [09.14.2022] (current) – external edit 127.0.0.1
Line 4: Line 4:
  
  
-<relatedarticles> [[home:patients:grappling_uncertainty|Grappling with uncertainty about the Marshall Protocol]], [[home:starting:physician:reluctant|Helping a reluctant physician]], [[home:physicians:concerns|Physicians' concerns and success rates for 5 Dx]]</article>+<relatedarticles> [[home:patients:grappling_uncertainty|Confronting uncertainty about the Marshall Protocol]], [[home:starting:physician:reluctant|Helping a reluctant physician]], [[home:physicians:concerns|Physicians' concerns and success rates for 5 Dx]]</article>
  
  
Line 21: Line 21:
 Early on the protocol MP patients' symptoms tend to wax and wane in a semi-predictable fashion and occur in expected locations. This is particularly true if a regular schedule of dosing is followed. However, as a patient's own immune response begins to take hold, predictability become more elusive. Patients may even notice new symptoms occurring in organs previously not known to be infected. The MP does not and cannot create new inflammation. Early on the protocol MP patients' symptoms tend to wax and wane in a semi-predictable fashion and occur in expected locations. This is particularly true if a regular schedule of dosing is followed. However, as a patient's own immune response begins to take hold, predictability become more elusive. Patients may even notice new symptoms occurring in organs previously not known to be infected. The MP does not and cannot create new inflammation.
  
-<blockquote> +Later on in the protocol, Biofilm is likely to break up, leading to unpredictable surges in immuno-pathology.  
-In cases where people have trouble grasping this concept, the biggest hurdle is to get them through the first phase of the treatment when the immunopathology is often strongest. If I have any dropouts, they come from this group – the people who can’t intellectually grasp the idea that they need to feel worse before they get better.+ 
 +<blockquote>  In cases where people have trouble grasping this concept, the biggest hurdle is to get them through the first phase of the treatment when the immunopathology is often strongest. If I have any dropouts, they come from this group – the people who can’t intellectually grasp the idea that they need to feel worse before they get better.
  
-//**Greg Blaney, MD**// </blockquote>+//**Greg Blaney, MD**//  
 +</blockquote>
  
 The immunopathological reaction (sometimes referred to as the Jarisch-Herxheimer reaction) is widely accepted as an indication of progress and, according to the literature, [[home:protocol:immunopathology|has been observed]] in at least ten different diseases and conditions. The immunopathological reaction (sometimes referred to as the Jarisch-Herxheimer reaction) is widely accepted as an indication of progress and, according to the literature, [[home:protocol:immunopathology|has been observed]] in at least ten different diseases and conditions.
Line 80: Line 82:
 Joyful 2015</blockquote> Joyful 2015</blockquote>
  
-[[http://www.greenmedinfo.com/blog/citizens-arms-against-5g-wireless-technology-roll-out-are-their-concerns-justifie|Citizens oppose 5G technology over multiple risks to health including heart arrhythmias and 50% reduction in neutrophil (immune) activity in vertebrate research ]]+[[https://www.greenmedinfo.com/blog/citizens-arms-against-5g-wireless-technology-roll-out-are-their-concerns-justifie|Citizens oppose 5G technology over multiple risks to health including heart arrhythmias and 50% reduction in neutrophil (immune) activity in vertebrate research ]]
  
 Women until past childbearing and boys not yet fully grown are particularly at risk. Women until past childbearing and boys not yet fully grown are particularly at risk.
 Aware parents are learning how to improve their children's lives, right from the start Aware parents are learning how to improve their children's lives, right from the start
-[[http://www.emfanalysis.com/safe-baby-monitor/|Safe Baby Monitor]]+[[https://www.emfanalysis.com/safe-baby-monitor/|Safe Baby Monitor]]
 ==== Troubleshooting a seemingly unresponsive immune system ==== ==== Troubleshooting a seemingly unresponsive immune system ====
  
Line 112: Line 114:
 So long as symptoms of immunopathology continue and elevated blood markers of bacterial die-off (such as BUN), there are bacteria being killed and to be killed. So long as symptoms of immunopathology continue and elevated blood markers of bacterial die-off (such as BUN), there are bacteria being killed and to be killed.
  
-The [[home:patients:mp_duration|range of time]] it takes seriously ill patients to recover on the Marshall Protocol is not entirely without precedent in medicine. The first-line treatment for for tuberculosis infection takes six months(({{pubmed>long:15982799}})) – and that's only a single genus as opposed to a [[home:pathogenesis:microbiota|metagenomic microbiota]]. It's also worth noting that recovery from tuberculosis also involves an immunopathological-type reaction.(({{pubmed>long:18600241}}))+The [[home:patients:mp_duration|range of time]] it takes seriously ill patients to recover on the Marshall Protocol is not entirely without precedent in medicine. The first-line treatment for for tuberculosis infection takes six months(({{pmid>long:15982799}})) – and that's only a single genus as opposed to a [[home:pathogenesis:microbiota|metagenomic microbiota]]. It's also worth noting that recovery from tuberculosis also involves an immunopathological-type reaction.(({{pmid>long:18600241}}))
  
 Patients should try to consider their responses to the MP medications logically. The [[home:protocol:olmesartan:safety|safety profile of olmesartan (Benicar)]] as well as the [[home:protocol:mp_antibiotics:antibiotics_concerns|safety profile of the MP antibiotics]] are excellent. The single best explanation for why a patient symptoms are worse is that the immune system is becoming stronger and microbes are being killed. Patients should try to consider their responses to the MP medications logically. The [[home:protocol:olmesartan:safety|safety profile of olmesartan (Benicar)]] as well as the [[home:protocol:mp_antibiotics:antibiotics_concerns|safety profile of the MP antibiotics]] are excellent. The single best explanation for why a patient symptoms are worse is that the immune system is becoming stronger and microbes are being killed.
Line 160: Line 162:
 {{tag>MP}}   {{tag>MP}}  
  
 +<nodisp>
 ===== Notes and comments ===== ===== Notes and comments =====
  
Line 165: Line 168:
  
   * Legacy content   * Legacy content
-    * http://www.marshallprotocol.com/forum32/2661.html f150 +    * https://www.marshallprotocol.com/forum32/2661.html f150 
-    * http://www.marshallprotocol.com/forum32/1822.html f330 +    * https://www.marshallprotocol.com/forum32/1822.html f330 
-    * http://www.marshallprotocol.com/forum32/5007.html f290    +    * https://www.marshallprotocol.com/forum32/5007.html f290    
-    * http://www.marshallprotocol.com/view_topic.php?id=1146&forum_id=32&jump_to=64346#p64346 f262 +    * https://www.marshallprotocol.com/view_topic.php?id=1146&forum_id=32&jump_to=64346#p64346 f262 
-    * http://www.marshallprotocol.com/forum32/1146.html#p9012 f261+    * https://www.marshallprotocol.com/forum32/1146.html#p9012 f261
   * Maximum frequency/amount of mino and Benicar dosing suggested to dampen IP appear outdated. --- //Joe Trunk 2008/12/26 16:47//   * Maximum frequency/amount of mino and Benicar dosing suggested to dampen IP appear outdated. --- //Joe Trunk 2008/12/26 16:47//
  
-===== References =====+===== References =====</nodisp> 
home/mp/progress.txt · Last modified: 09.14.2022 by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.